« previous next »
Pages: [1]

Author Topic: (Abst.) Fingolimod effect on gray matter, thalamus and white matter in PwMS  (Read 159 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Fingolimod effect on gray matter, thalamus and white matter in PwMS
« on: March 16, 2018, 11:51:28 am »

The researchers conclude that:
Quote


Fingolimod significantly reduced dGM volume loss (including thalamus) vs placebo in patients with RRMS. Reducing dGM and thalamic volume loss might improve long-term outcome.


From PubMed, March 16, 2018:https://www.ncbi.nlm.nih.gov/pubmed/29540589
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics